NEWSROOM

PRESS RELEASES

IN THE NEWS

LOGO LIBRARY

Recent News

News from ACR Convergence 2024

Lupus Therapeutics Statement on Phase 3 PHOENYCS GO Positive Data In Moderate-To-Severe Systemic Lupus

Washington, DC, November 19, 2024 – Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance (LRA), is encouraged...

News from ACR Convergence 2024

ACR Released a Summary of the 2024 ACR Guideline for the Screening, Treatment, and Management of Lupus Nephritis

Washington, DC, November 18, 2024 — The American College of Rheumatology (ACR) released a summary of the 2024 ACR Guideline...

Announcing LRA-supported research studies at ACR

Lupus Research Alliance Announces Lupus Research Highlights at ACR Convergence 2024

New York, NY, November 4, 2024 – Sixteen presentations of preclinical studies funded by the Lupus Research Alliance to advance understanding...

Gazyva® Shows Positive Results in Phase 3 Lupus Nephritis Trial

New York, NY, September 25, 2024 — The Lupus Research Alliance (LRA) and clinical research affiliate Lupus Therapeutics (LT) are...

Investigational Treatment Dapirolizumab Pegol Shows Positive Results in Phase 3 Clinical Trial

New York, NY, September 24, 2024 — Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance, is proud...

Statement in Response to Recent Lupus Science and Medicine Publication

New York, NY, July 16, 2024 — A study recently published in Lupus Science and Medicine showed that krill oil...

Placeholder Image

On “Lupus Call to Action Day”, the Lupus Research Alliance and Lupus Therapeutics Amplify a Call for Equity and Inclusion

New York, NY, May 1, 2024 — As part of Lupus Awareness Month, May 1 has been declared “Lupus Call...

Placeholder Image

Lupus Peer-to-Peer Early Education Program Expands

New York, NY, March 28, 2024 — Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance, has announced...

Placeholder Image

Lupus Therapeutics Announces Collaboration to Support the Evaluation of Non-Genetically Modified Cell-Based Therapy for Lupus Nephritis with Artiva Biotherapeutics

New York, NY, March 14, 2024 — Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance, announced a...